Environmental

MSPR shows no disclosed R&D intensity or emissions metrics in the provided data, limiting peer comparison on environmental management versus more transparent healthcare peers.

The absence of reported environmental capital allocation signals suggests a neutral-to-lagging disclosure profile relative to peers that publish climate, waste, or resource-use targets.

No evidence of material environmental controversies is provided, which avoids a clear disadvantage, but the company still appears less mature than peers on environmental reporting.

Social

The provided metrics do not disclose workforce, patient, or community indicators, so MSPR cannot be shown to outperform peers on social transparency.

Zero stock-based compensation to revenue may indicate limited equity dilution pressure, but it does not materially differentiate social practices versus peers.

Without disclosed safety, turnover, diversity, or customer-impact data, MSPR’s social positioning remains broadly average to slightly below more transparent peers.

Governance

A net debt to EBITDA ratio of 6.0x indicates materially higher leverage than many peers, increasing governance scrutiny over capital discipline and risk oversight.

The negative debt-to-equity ratio suggests an atypical balance-sheet structure, which can complicate peer comparison and raises questions about financial reporting clarity.

No stock-based compensation burden is disclosed, which is favorable versus peers with heavier dilution, but it is not enough to offset leverage-related governance concerns.

Overall Score

MSPR’s ESG positioning is broadly average to slightly weak versus peers because limited disclosure is offset by elevated leverage-related governance risk.

Score Driver: Elevated Leverage And Limited ESG Disclosure Relative To Peers.